Conolog Corporation (CNLG) Reports a Q3 Loss
More News related to CNLG
- Conolog Announces Completion of Field Testing of "GlowWorm" Fiber Optic Detector
- Conolog Corp. (CNLG) Receives $300K Order for 1049 Switches and Other Communication Equipment
- Conolog Announces Orders for Switches and Other Equipment Valued at over $300,000 for Immediate Delivery
- Unusual 11 Mid-Day Movers 9/28: TIV, ASPM, CNLG, GETI, GMTN Higher; FRP, CLSN, XRX, DRAM Lower
- Conolog (CNLG) Sees Upside Action... Again
More News related to Earnings
- Kinross Gold (KGC) Receives Authorization to Re-Commence Exploration on Project in Ecuador
- Sanofi-aventis (SNY) and Regeneron Pharmaceuticals (REGN) to Expand Global Collaboration
- Stryker (SYK) Announces Two Acquisitions
- Adobe (ADBE) Cutting 680 Full-Time Jobs to Align Costs with '10 Operating Plan
- Teva Pharma (TEVA) Gets Final U.S. FDA Approval for Generic Prevacid
Conolog Corporation (Nasdaq: CNLG) reports a Q3 loss of $0.53 compared to a $0.62 loss for the same period last year.
Product revenues increased 87% to $135,708 for the fiscal quarter ended April 30, 2007 compared to $72,462 in the fiscal quarter ended April 30, 2006.
Related Categories
EarningsStocks Mentioned
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
